stockrow
Friday 6 November 2026
Export HSTM’s income statement to Excel — free account
HealthStream, Inc.
HSTM Healthcare Health Information Services
HealthStream, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $304.1 million, up 4.26% from fiscal 2024.
- Revenue
- +8.94%
- EPS
- −8.90%
- Free cash flow
- −4.80%
Quarter to September 2026, against a year earlier
28.78
0.82
−2.77%
Follow HSTM
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
37.82 | 30.91 | 37.85 | 42.31 |
P/S ratio |
2.28 | 1.95 | 2.48 | 2.67 | |
P/FCF ratio |
11.60 | 10.13 | 11.40 | 12.70 | |
P/Operating CF |
52.50 | 22.42 | 59.30 | 50.38 | |
P/B ratio |
1.96 | 1.73 | 2.23 | 2.18 | |
Price to Tangible BV |
9.68 | 8.04 | 9.49 | 6.60 | |
EV/Sales |
2.18 | 1.83 | 2.36 | 2.41 | |
EV/EBITDA |
8.69 | 7.10 | 9.04 | 9.42 | |
EV/Operating CF |
10.48 | 8.99 | 10.56 | 11.09 | |
EV/FCF |
11.12 | 9.49 | 10.85 | 11.43 | |
Quick Ratio |
0.77 | 0.81 | 0.84 | 1.27 | |
Current Ratio |
0.96 | 0.97 | 1.06 | 1.48 | |
Net Debt/EBITDA |
(3.38) | (3.00) | (2.88) | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.59 | 0.59 | 0.63 | 0.62 | |
Operating CF/Net income |
5.20 | 4.59 | 2.01 | 3.24 | |
Capex/Depreciation |
(0.01) | (0.05) | (0.06) | (0.02) | |
Research and Development Expense of Revenue |
18.51% | 16.76% | 16.22% | 16.23% | |
Selling, General and Administrative Expense of Revenue |
28.43% | 25.81% | 25.72% | 26.31% | |
Intangible Assets out of Total Assets |
0.54 | 0.52 | 0.52 | 0.48 | |
Share Based Compensation of Revenue |
6.79% | 1.61% | 1.32% | 1.44% | |
Graham Net Nets |
(0.07) | (0.07) | (0.04) | 0.02 | |
Graham Number |
12.72 | 13.44 | 14.06 | 14.67 | |
Earnings Yield |
2.64% | 3.24% | 2.64% | 2.36% | |
Free Cash Flow Yield |
8.62% | 9.87% | 8.77% | 7.88% | |
Revenue per Share |
2.66 | 2.76 | 2.86 | 2.82 | |
Operating CF per Share |
0.44 | 0.92 | 0.46 | 0.59 | |
Capex per Share |
(0.01) | (0.03) | (0.03) | (0.01) | |
Free Cash Flow per Share |
0.43 | 0.90 | 0.43 | 0.58 | |
Cash per Share |
1.90 | 2.26 | 2.28 | 3.91 | |
Shareholders Equity per Share |
11.79 | 11.98 | 12.20 | 13.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.79 | 11.98 | 12.20 | 13.63 | |
Free Cash Flow |
13.03 | 26.40 | 12.52 | 17.06 | |
Working Capital |
(4.49) | (3.49) | 7.59 | 58.17 | |
Capital Expenditures |
(0.16) | (0.74) | (0.91) | (0.33) | |
Net Current Asset Value |
(46.69) | (42.43) | (34.77) | 15.45 | |
EV/EBIT |
32.79 | 24.39 | 29.37 | 31.78 | |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.00 | |
Price to Operating Income |
34.22 | 26.03 | 30.87 | 35.29 | |
| Other line items | |||||
Average Receivables |
37.16 | 39.77 | 34.14 | 36.22 | |
Average Payables |
7.20 | 4.13 | 5.43 | 16.63 | |
Average Assets |
515.57 | 525.74 | 510.87 | 532.89 | |
Average Common Equity |
356.69 | 357.40 | 353.59 | 375.57 |
Columns are period end dates · fundamentals updated 5 Nov 2026